Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease
NCT00165737 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 974
Last updated 2011-04-01
Summary
Twenty-four week, prospective, randomized, double-blind, placebo-controlled, parallel-group study.
Conditions
- Dementia, Vascular
Interventions
- DRUG
-
Donepezil Hydrochloride
Sponsors & Collaborators
-
Eisai Inc.
lead INDUSTRY
Principal Investigators
-
Holly Posner · Eisai Inc.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 41 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-03-31
- Primary Completion
- 2005-08-31
- Completion
- 2006-06-30
Countries
- United States
Study Locations
More Related Trials
-
The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment
NCT00103948 ·Status: COMPLETED ·Phase: PHASE2
-
A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease
NCT01404169 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia
NCT00165763 ·Status: COMPLETED ·Phase: PHASE4
-
Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-
NCT01129596 ·Status: COMPLETED
-
Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease
NCT02097056 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Donepezil in Mild to Moderate Alzheimer's Disease
NCT02787746 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease
NCT00096473 ·Status: COMPLETED ·Phase: PHASE3
-
Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease
NCT01539031 ·Status: COMPLETED ·Phase: PHASE3
-
Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's Disease
NCT02162251 ·Status: COMPLETED
-
Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's Disease
NCT01251718 ·Status: COMPLETED
-
A Randomized, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil in Subjects With MCI
NCT00483028 ·Status: COMPLETED ·Phase: NA
-
Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease
NCT01082965 ·Status: TERMINATED ·Phase: NA
-
Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice
NCT02162264 ·Status: COMPLETED
-
Donepezil to Treat Dementia in Parkinson's Disease
NCT00030979 ·Status: COMPLETED ·Phase: PHASE4
-
A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease
NCT00988598 ·Status: COMPLETED ·Phase: PHASE1
-
Brain Imaging and Mental Disorders of Aging Intervention
NCT00267163 ·Status: COMPLETED ·Phase: PHASE4
-
BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
NCT02337907 ·Status: COMPLETED ·Phase: PHASE2
-
Memory Impairment Study (Mild Cognitive Impairment Study)
NCT00000173 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil
NCT01024660 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease
NCT00408525 ·Status: COMPLETED ·Phase: PHASE1
-
A Double-blind Study of E2020 (Donepezil Hydrochloride) in Patients With Dementia With Lewy Bodies (DLB) (Study E2020-J081-431)
NCT00543855 ·Status: COMPLETED ·Phase: PHASE2
-
Hippocampus Study: Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological Markers
NCT00403520 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease
NCT00711204 ·Status: WITHDRAWN ·Phase: PHASE4
-
Safety, Tolerability, and Efficacy of Donepezil (Aricept) in Parkinson' s Disease (PD) Patients With Dementia
NCT01327859 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment for Early Memory Loss
NCT00042172 ·Status: COMPLETED ·Phase: PHASE4